Print Options
PrintThe Whole
Act
PrintThe Whole
Part
PrintThe Whole
Cross Heading
PrintThis
Section
only
Changes over time for: Section 25
Llinell Amser Newidiadau
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Status:
Point in time view as at 01/10/2012.
Changes to legislation:
Health Act 2009, Section 25 is up to date with all changes known to be in force on or before 26 November 2024. There are changes that may be brought into force at a future date. Changes that have been made appear in the content and are referenced with annotations.
Changes to Legislation
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
25Pharmaceutical needs assessmentsE+W
This
adran has no associated
Nodiadau Esboniadol
After section 128 of the National Health Service Act 2006 (c. 41) insert—
“128APharmaceutical needs assessments
(1)Each Primary Care Trust must in accordance with regulations—
(a)assess needs for pharmaceutical services in its area, and
(b)publish a statement of its first assessment and of any revised assessment.
(2)The regulations must make provision—
(a)as to information which must be contained in a statement;
(b)as to the extent to which an assessment must take account of likely future needs;
(c)specifying the date by which a Primary Care Trust must publish the statement of its first assessment;
(d)as to the circumstances in which a Primary Care Trust must make a new assessment.
(3)The regulations may in particular make provision—
(a)as to the pharmaceutical services to which an assessment must relate;
(b)requiring a Primary Care Trust to consult specified persons about specified matters when making an assessment;
(c)as to the manner in which an assessment is to be made;
(d)as to matters to which a Primary Care Trust must have regard when making an assessment.”
Yn ôl i’r brig